Clinical Trial Update: Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET]

View source ↗

Summary

Clinical trial update describing the use of hybrid MRI-PET molecular imaging to characterize metastatic penile cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Cancer

Snippet

Sponsor: Queen Mary University of London | Conditions: Squamous Cell Carcinoma of the Penis | Status: COMPLETED